Ligand, Sankyo Company Ltd. deal

Sankyo (Tokyo) invested $1.5 million in LGND, purchasing 189,274 shares of the San Diego company at $7.93. In July 1994, Sankyo entered into an agreement with Glycomed to develop cell adhesion modulat...